Target intelligence / Profile preview

Cytochrome P450 2C6 (CYP2C6)

Target: CYP2C6
Molecular classification: Cytochrome P450 enzyme, CYP2C subfamily, Monooxygenase

Overview

There is no recognized human pharmacological target named "CYP2C6." CYP2C6 is a member of the cytochrome P450 2C subfamily, primarily characterized in rats, and does not represent a standard human drug metabolism enzyme or therapeutic target. If human drug metabolism or pharmacogenomic relevance is intended, CYP2D6 or closely related human CYP2C isoforms (such as CYP2C9 or CYP2C19) should be considered instead.

Biological functions

Drug metabolism (rat isoform)

Beyond the preview

Go deeper on Cytochrome P450 2C6 (CYP2C6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 2C6 (CYP2C6).

Explore the full profile